Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone
Status:
Completed
Trial end date:
2019-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of sublingual naloxone in the
treatment of chronic itch in patients under arsenic exposure.